Epizyme Inc is a clinical stage biopharmaceutical company. The Company discovers, develops and commercializes novel epigenetic therapies for cancer patients.
$10.19 -0.22 (-2.11%)
As of 02/24/2021 15:59:53 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.